LUXA BIOTECHNOLOGY LLC
🇺🇸United States
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD)
Phase 1
Recruiting
- Conditions
- Dry Age-related Macular Degeneration
- Interventions
- First Posted Date
- 2020-11-13
- Last Posted Date
- 2025-07-24
- Lead Sponsor
- Luxa Biotechnology, LLC
- Target Recruit Count
- 18
- Registration Number
- NCT04627428
- Locations
- 🇺🇸
Retina Vitreous Associates Medical Group, Beverly Hills, California, United States
🇺🇸Spencer Center for Vision Research, Palo Alto, California, United States
🇺🇸University of Michigan Kellogg Eye Center, Ann Arbor, Michigan, United States
News
No news found